Genomic and Transcriptomic Profiling of Triple Negative Breast Cancer Patients Treated with Paclitaxel and Eribulin Containing Neoadjuvant Chemotherapy and Response Prediction (original) (raw)

Academia.edu no longer supports Internet Explorer.

To browse Academia.edu and the wider internet faster and more securely, please take a few seconds to upgrade your browser.